A Multiple Dose Study to Assess the Safety and Tolerability of BMS-963272 in Obese But Otherwise Healthy Adults

For more information regarding Bristol-Myers Squibb Clinical Trial participation, please visit www.BMSStudyConnect.com Inclusion Criteria: * Participants must be in good general health, in the opinion of the investigator, with no clinically significant deviation from normal in medical history, physical examination findings, ECGs, or laboratory results. * Participants must have a BMI of 30 kg/m2 to 40 kg/m2 inclusive * Women (not of childbearing potential) and men aged 18 to 60 years, inclusive Exclusion Criteria: * Previous participation in the current study * Inability or unwillingness to comply with protocol-defined restrictions or requirements regarding lifestyle, diet, concomitant medications, or other aspects of the study * Inability to tolerate the oLTT meal or to comply with oLTT testing conditions * Inability to tolerate oral medication * Inability to tolerate venipuncture and/or inadequate venous access * Women who are breastfeeding * Medical Conditions * History of lactose intolerance * Any significant (in the opinion of the investigator) acute or chronic illness * Type 1 or 2 diabetes * Evidence of organ dysfunction or any clinically significant deviation from normal in physical examination, vital signs, ECG, or clinical laboratory determinations beyond what is consistent with the target population * Previous/Concomitant Therapy * Previous exposure to BMS-963272 Other protocol-defined inclusion/exclusion criteria could apply